Trial Outcomes & Findings for Evaluation of the Performance of the CleanC System-Israel (NCT NCT02387268)
NCT ID: NCT02387268
Last Updated: 2017-09-20
Results Overview
Scale ranges- Min-0, Max-3 where: 0 = Unprepared colon segment with mucosa not seen due to solid stool that cannot be cleared. 1. = Portion of mucosa of the colon segment seen, but other areas of the colon segment not well seen due to staining, residual stool and/or opaque liquid. 2. = Minor amount of residual staining, small fragments of stool and/or opaque liquid, but mucosa of colon segment seen well. 3. = Entire mucosa of colon segment seen well with no residual staining, small fragments of stool or opaque liquid. The wording of the scale was finalized after incorporating feedback from three colleagues experienced in colonoscopy.
COMPLETED
NA
10 participants
During the colonoscopy procedure withdrawal phase (10 min in average)
2017-09-20
Participant Flow
Participant milestones
| Measure |
CleanC
Standard colonoscopy procedure using the CleanC system
CleanC system: Cleansing liquid and fecal matter during a standard colonoscopy procedure
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
9
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluation of the Performance of the CleanC System-Israel
Baseline characteristics by cohort
| Measure |
CleanC
n=10 Participants
Standard colonoscopy procedure using the CleanC system
CleanC system: Cleansing liquid and fecal matter during a standard colonoscopy procedure
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=5 Participants
|
|
Age, Continuous
|
52.3 years
STANDARD_DEVIATION 13 • n=5 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Region of Enrollment
Israel
|
10 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: During the colonoscopy procedure withdrawal phase (10 min in average)Scale ranges- Min-0, Max-3 where: 0 = Unprepared colon segment with mucosa not seen due to solid stool that cannot be cleared. 1. = Portion of mucosa of the colon segment seen, but other areas of the colon segment not well seen due to staining, residual stool and/or opaque liquid. 2. = Minor amount of residual staining, small fragments of stool and/or opaque liquid, but mucosa of colon segment seen well. 3. = Entire mucosa of colon segment seen well with no residual staining, small fragments of stool or opaque liquid. The wording of the scale was finalized after incorporating feedback from three colleagues experienced in colonoscopy.
Outcome measures
| Measure |
CleanC
n=9 Participants
Standard colonoscopy procedure using the CleanC system
CleanC system: Cleansing liquid and fecal matter during a standard colonoscopy procedure
|
|---|---|
|
Percentage Subjects With Post Procedure Cleansing Level as Measured by the Boston Bowel Preparation Scale (BBPS) Adequate Cleansing-(BBPS>1 )
|
88.9 percentage of participants
Interval 51.7 to 99.7
|
PRIMARY outcome
Timeframe: Max of 9 daysOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During the colonoscopy procedureA procedure was considered complete when the cecum was reached and visualized.
Outcome measures
| Measure |
CleanC
n=9 Participants
Standard colonoscopy procedure using the CleanC system
CleanC system: Cleansing liquid and fecal matter during a standard colonoscopy procedure
|
|---|---|
|
Percentage of Participants in Whom the Cecum Was Reached
|
88.9 percentage of participants
Interval 51.7 to 99.7
|
Adverse Events
CleanC
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
CleanC
n=10 participants at risk
Standard colonoscopy procedure using the CleanC system
CleanC system: Cleansing liquid and fecal matter during a standard colonoscopy procedure
|
|---|---|
|
Gastrointestinal disorders
Mild abdominal pain
|
10.0%
1/10 • Number of events 1
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place